Rebecca Shortle

Rebecca Shortle has a diverse work experience spanning several industries. Rebecca is currently serving as the Senior Director and Head of Intellectual Property at Frontier Medicines. Prior to this, they had their own fine art business called Rebecca Shortle Fine Art.

In 2019, Rebecca joined PTC Therapeutics, Inc. as the Director of Intellectual Property, following the acquisition of BioElectron Technology Corp. Earlier, they held the positions of Senior Director and Director of Intellectual Property at BioElectron Technology Corporation from 2013 to 2019.

Rebecca also has a background in law. Rebecca worked as an Associate at Morrison & Foerster LLP from 2007 to 2011. Prior to that, they served as a Law Clerk from 2004 to 2007 and as a Patent Agent from 1999 to 2004 at the same firm.

Rebecca Shortle has pursued a diverse range of academic interests throughout their educational journey. Rebecca holds a Juris Doctor (JD) degree from the University of California, Berkeley - School of Law, emphasizing their dedication to the field of Law. Prior to that, they completed a Master of Arts (MA) degree in Chemistry at Harvard University, demonstrating their proficiency in the scientific discipline. Rebecca also obtained a Bachelor of Arts (BA) degree in Chemistry from Pomona College, showing their continued interest in this subject.

In addition to their scientific pursuits, Rebecca has a passion for Fine Arts. To further their artistic skills, they enrolled in the San Francisco Art Institute and the Parsons Paris School of Art and Design, where they studied Fine Arts. Although the specific degrees they obtained from these institutions are not mentioned, they indicate their commitment to developing their artistic abilities.

The information provided does not include details about the start and end years for each educational experience, but it portrays Rebecca Shortle as a well-rounded individual with a strong academic background in Law, Chemistry, and Fine Arts.